Pictet Asset Management (UK)’s Molecular Templates, Inc. MTEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$20.9M Buy
178,100
+345
+0.2% +$45.2K 0.02% 509
2021
Q1
$33.6M Buy
177,755
+20,000
+13% +$3.51M 0.04% 408
2020
Q4
$22.2M Buy
157,755
+91,463
+138% +$13.5M 0.03% 456
2020
Q3
$10.9M Buy
+66,292
New +$11.8M 0.02% 536

Other funds holding MTEM

Pictet Asset Management (UK)'s MTEM Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Molecular Templates, Inc. (MTEM) stake by 0.19% in Q2 2021, buying an estimated $45.2K and bringing the position to 178,100 shares worth $20.9M. The position accounts for 0.02% of the portfolio, ranked #509.

Pictet Asset Management (UK) first reported a position in MTEM in Q3 2020 and has held it in 4 quarters since. The position peaked at $33.6M in Q1 2021. 89 funds tracked by Wall St. Rank hold MTEM as of Q2 2021.

  • Pictet Asset Management (UK) held 178,100 shares of Molecular Templates, Inc. worth $20.9M as of Q2 2021.
  • Pictet Asset Management (UK) bought 345 Molecular Templates, Inc. shares in Q2 2021, an estimated $45.2K.
  • Molecular Templates, Inc. made up 0.02% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #509 holding.
  • Pictet Asset Management (UK) first reported a position in Molecular Templates, Inc. in Q3 2020 and has held it in 4 quarters since.
  • Pictet Asset Management (UK)'s Molecular Templates, Inc. position peaked at $33.6M in Q1 2021.
  • 89 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.